ArticleJournal of human hypertension2026
Pulse wave velocity in high-risk pregnant women who subsequently developed early- and late-onset preeclampsia.
Article in Journal of human hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We conducted a prospective study in consecutive high-risk pregnant women with 8 to 34 weeks of gestation to evaluate the relationship between PWV and the subsequent development of early- and late- onset preeclampsia (PE). The cohort was divided in high PWV (defined by the top tertile) and normal PWV (the remaining two tertiles). PE were classified as late-onset PE and early- onset PE using a cut-point of 34 weeks of gestation. The risk of women with high PWV for early- and late-onset PE was compared with women with normal PWV using multinomial regression. Two hundred and sixty-three high-risk pregnant women (mean age 30 ± 7 years, with 26 ± 7 weeks of gestation at the evaluation) were included in the study; 7.4%, 22.6%, 1.2%, 3.1% and 0.8% had antecedents of diabetes, chronic hypertension, chronic renal disease, collagen diseases and antiphospholipid syndrome, respectively. In previous pregnancies, 11.3% had had gestational diabetes and 22,6% hypertensive disorders of pregnancy. Forty-six pregnant women (17.9%) developed PE, of which 31 (12.1%) were late-onset and 15 (5.8%) early-onset. Women with high PWV more frequently developed early-onset than late-onset PE (14.0% vs 11.8% p = 0.509). Unadjusted and adjusted OR for early-onset PE were 9.61 (95%CI 2.62-35.25) and 7.13 (1.89-26.71), respectively. In conclusion, in high-risk pregnant women, a high PWV value was related with ~7 times more risk for development of early-onset PE.
Indexed as
Identifiers
41272288What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.